移植中的非HLA抗体:全面的见解和临床影响
Oumayma Ratbi1, Imane Yakhlef2, Sanae Ouadghiri2
1Laboratory of Immunology, Faculty of Medicine and Pharmacy, Ibn Zohr University, Agadir, Morocco, Laboratory of Research and Innovation in Health Sciences (LARISS).
Annales de biologie clinique
|March 3, 2026
概括
非HLA抗体 (n-HLab) 可能表明器官移植后无法解释的抗体中介排斥 (ABMR). 然而,它们的直接临床影响和诊断标准化需要在日常使用之前进行进一步的研究.
科学领域:
- * 移植免疫学 移植免疫学
- * 腎病學 腎病學
- * 自身免疫性 自身免疫性
背景情况:
- *人类白细胞抗原 (HLA) 供体特异性抗体 (DSA) 是抗体介导排斥 (ABMR) 的主要驱动因素.
- * 尽管没有DSA,但ABMR病例的很大一部分 (20-30%) 发生,称为"DSA阴性"排斥.
- * 这些不明原因的排斥在全移植管理中构成了临床挑战.
研究的目的:
- * 审查非HLA抗体 (n-HLab) 在无法解释的移植损伤中的新兴作用.
- * 探索n-HLab作为ABMR生物标志物的潜力.
- *讨论n-HLab研究当前的局限性和未来的方向.
主要方法:
- * 在器官移植拒绝的背景下研究非HLA抗体的研究文献综述.
- * 分析将内皮应激与自身抗原释放联系起来的病理生理机制.
- *评估与n-HLab相关的当前诊断和治疗策略.
主要成果:
- * 缺血-再输液损伤和内皮应激可以暴露密码的自身抗原 (例如,AT1R,ETAR,LG3,维丁,MICA) 在全移植.
- *观察性研究将n-HLab与严重的血管排斥联系在一起,但因果关系尚未确立.
- *目前的证据不证实使用n-HLab监测或向治疗改善了临床结果.
结论:
- *非HLA抗体是未解释的ABMR中风险分层的一个有希望的领域.
- *需要标准化测试和共识值才能进行可靠的诊断.
- * 在实践中常规实施之前,进一步的临床验证是必不可少的.
相关概念视频
Kidney Transplant I: Introduction
600
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
600
Kidney Transplant II: Surgical Procedure
579
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
579
Kidney Transplant III: Nursing Management
466
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
466
Cell-mediated Immune Responses
85.2K
Overview
85.2K
Tissue Transplantation
1.1K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K
Blood Transfusion and Agglutination
15.1K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
15.1K


